<DOC>
	<DOC>NCT00086138</DOC>
	<brief_summary>The purpose of this study is to learn whether treating individuals with Alzheimer's disease and depression with the anti-depressant medication sertraline (Zoloft) is helpful to people with Alzheimer's disease and to their families and caregivers.</brief_summary>
	<brief_title>Depression in Alzheimer's Disease-2</brief_title>
	<detailed_description>Participants are randomly assigned to treatment with sertraline (range 25-125 mg per day) or identical placebo for 24 weeks. There are 8 scheduled in-person visits in the 24 weeks. Visits include neuropsychological testing. Caregivers are asked to are the patient on a Daily Affect Diary for 6 weeks during the study period. Telephone followup is done at weeks 36 and 48. Both groups receive caregiver support/education.</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<criteria>Inclusion: Ability of the participant, caregiver or surrogate to provide written informed consent. Dementia due to Alzheimer's disease Stable treatment for Alzheimer's disease Ability for the participant's caregiver to accompany the participant to study visits and participate in the study. Exclusion Presence of a brain disease that might otherwise explain the presence of dementia Clinically significant hallucinations or delusions Current treatment of antipsychotics, anticonvulsants, and other antidepressants, benzodiazepines, or other psychotropic medications Need for hospitalization or residence in a nursing facility</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Alzheimer's disease</keyword>
	<keyword>Depression</keyword>
</DOC>